Clinical Trials Directory

Trials / Completed

CompletedNCT05270980

COVID-19 Serologic Strategies for Skilled Nursing Facilities

COVID-19 Serologic Strategies for Skilled Nursing Facilities (CERO)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
87 (actual)
Sponsor
NYU Langone Health · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The COVID-19 pandemic ravaged United States skilled-nursing facilities (SNFs). Novel strategies that maximize the safety and quality of life for SNF residents with ADRD and staff who care for them are urgently needed. Thus, the study's objectives are: 1. To rapidly plan and pilot test an intervention that leverages COVID-19 antibody and PCR status to pair SNF staff with residents in the safest way possible 2. To reduce reduced COVID-19 incidence rate compared to SNFs not using this novel staff-resident assignment strategy.

Conditions

Interventions

TypeNameDescription
OTHERCohortingThe cohorting strategy will result in "pairing" serology-positive staff with serology-negative residents and serology-negative staff and serology-positive residents to the degree that penetration of serologic presumed immunity allows this pairing to be positive. Any resident who refuses serology testing will be treated as if they are serology negative as the safest strategy for risk of unwanted exposure.

Timeline

Start date
2021-08-11
Primary completion
2022-02-04
Completion
2022-02-04
First posted
2022-03-08
Last updated
2023-04-06
Results posted
2023-04-06

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT05270980. Inclusion in this directory is not an endorsement.